These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27475056)

  • 21. Regulatory chills: tobacco industry legal threats and the politics of tobacco standardised packaging in New Zealand.
    Crosbie E; Thomson G
    N Z Med J; 2018 Apr; 131(1473):25-41. PubMed ID: 29649194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco product developments coinciding with the implementation of plain packaging in Australia.
    Scollo M; Occleston J; Bayly M; Lindorff K; Wakefield M
    Tob Control; 2015 Mar; 24(e1):e116-22. PubMed ID: 24789601
    [No Abstract]   [Full Text] [Related]  

  • 23. A multi-level, multi-jurisdictional strategy: Transnational tobacco companies' attempts to obstruct tobacco packaging restrictions.
    Hawkins B; Holden C; Mackinder S
    Glob Public Health; 2019 Apr; 14(4):570-583. PubMed ID: 29521160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Industry influence over global alcohol policies via the World Trade Organization: a qualitative analysis of discussions on alcohol health warning labelling, 2010-19.
    Barlow P; Gleeson D; O'Brien P; Labonte R
    Lancet Glob Health; 2022 Mar; 10(3):e429-e437. PubMed ID: 35120586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SEATCA Tobacco Industry Interference Index: a tool for measuring implementation of WHO Framework Convention on Tobacco Control Article 5.3.
    Assunta M; Dorotheo EU
    Tob Control; 2016 May; 25(3):313-8. PubMed ID: 25908597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The taste of smoke: tobacco industry strategies to prevent the prohibition of additives in tobacco products in Brazil.
    Oliveira da Silva AL; Bialous SA; Albertassi PGD; Arquete DADR; Fernandes AMMS; Moreira JC
    Tob Control; 2019 Dec; 28(e2):e92-e101. PubMed ID: 31152115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective longitudinal study of tobacco company adaptation to standardised packaging in the UK: identifying circumventions and closing loopholes.
    Evans-Reeves KA; Hiscock R; Lauber K; Gilmore AB
    BMJ Open; 2019 Sep; 9(9):e028506. PubMed ID: 31551373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UK government may face legal challenge from Philip Morris over plain cigarette packaging.
    O'Dowd A
    BMJ; 2014 Aug; 349():g5172. PubMed ID: 25128487
    [No Abstract]   [Full Text] [Related]  

  • 29. Strong public support for plain packaging of tobacco products.
    Hoek J; Gendall P; Maubach N; Edwards R
    Aust N Z J Public Health; 2012 Oct; 36(5):405-7. PubMed ID: 23025358
    [No Abstract]   [Full Text] [Related]  

  • 30. Approaches for controlling illicit tobacco trade--nine countries and the European Union.
    Ross H; Husain MJ; Kostova D; Xu X; Edwards SM; Chaloupka FJ; Ahluwalia IB;
    MMWR Morb Mortal Wkly Rep; 2015 May; 64(20):547-50. PubMed ID: 26020137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opening windows and closing gaps: a case analysis of Canada's 2009 tobacco additives ban and its policy lessons.
    Lencucha R; Ruckert A; Labonte R; Drope J
    BMC Public Health; 2018 Nov; 18(1):1321. PubMed ID: 30486817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protecting the plain packaging consultation from tobacco industry interference.
    Smith J; Lee K
    CMAJ; 2016 Oct; 188(14):E340-E341. PubMed ID: 27551036
    [No Abstract]   [Full Text] [Related]  

  • 33. Tobacco industry and public health responses to state and local efforts to end tobacco sales from 1969-2020.
    McDaniel PA; Malone RE
    PLoS One; 2020; 15(5):e0233417. PubMed ID: 32442202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A health professional's guide to the intersection of public health with intellectual property rights in trade and investment: the case of tobacco plain packaging.
    Pley C; van der Heijden MR; Tulinius C
    J Public Health Policy; 2020 Mar; 41(1):52-62. PubMed ID: 31685934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.
    Crosbie E; Bialous S; Glantz SA
    Tob Control; 2019 Dec; 28(e2):e110-e118. PubMed ID: 30659106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'It will harm business and increase illicit trade': an evaluation of the relevance, quality and transparency of evidence submitted by transnational tobacco companies to the UK consultation on standardised packaging 2012.
    Evans-Reeves KA; Hatchard JL; Gilmore AB
    Tob Control; 2015 Jun; 24(e2):e168-77. PubMed ID: 25472733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Breakthrough with the TPP: The Tobacco Carveout.
    Puig S; Shaffer G
    Yale J Health Policy Law Ethics; 2016; 16(2):327-33. PubMed ID: 29756754
    [No Abstract]   [Full Text] [Related]  

  • 38. Young Adult Perceptions of the British American Tobacco New Zealand Agree/Disagree Plain Packaging Counter-Campaign.
    McCool J; Wong-Cornall C; Freeman B
    Nicotine Tob Res; 2017 Oct; 19(10):1192-1198. PubMed ID: 27613924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness of plain packaging in discouraging tobacco consumption in Australia.
    Underwood D; Sun S; Welters RAMHM
    Nat Hum Behav; 2020 Dec; 4(12):1273-1284. PubMed ID: 32958901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The devil is in the detail: tobacco industry political influence in the Dutch implementation of the 2001 EU Tobacco Products Directive.
    Lie JL; Willemsen MC; de Vries NK; Fooks G
    Tob Control; 2016 Sep; 25(5):545-50. PubMed ID: 26349910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.